Stay updated on Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    No additions or deletions were detected on the page; the visible content appears unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T20:37:31.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    - Updated operating status notice and new version tag (v3.2.0) replacing v3.1.0. The page now informs users about potential delays due to funding and directs to official sources for status; previous version marker v3.1.0 was removed.
    Difference
    3%
    Check dated 2025-10-06T04:28:02.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Added revision: v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older revision tag v3.0.2.
    Difference
    0.4%
    Check dated 2025-09-29T00:00:26.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Updated to v3.0.2 (Sept 2025) with new 2025 dates and an estimated last-update label. Added ACT17131 plain-language results link from Sanofi/Principia Biopharma, while older entries, revision v3.0.1, and 'Back to Top' were removed.
    Difference
    1%
    Check dated 2025-09-14T18:45:39.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T13:13:01.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and specific drug safety information, while removing previous location details and references to certain diseases.
    Difference
    2%
    Check dated 2025-08-31T09:50:34.000Z thumbnail image

Stay in the know with updates to Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.